Kathleen Boyle

Title: Kathleen Boyle: Innovator in Genetic Engineering

Introduction

Kathleen Boyle is a prominent inventor based in Alameda, CA (US). She has made significant contributions to the field of genetic engineering, particularly in the development of modified B cells for therapeutic applications. Her innovative work aims to address various diseases and disorders, showcasing her commitment to advancing medical science.

Latest Patents

Kathleen Boyle holds a patent for her invention titled "Modified B cells and methods of use thereof." This patent relates to genetically modified B cells that can be utilized for the treatment of a variety of diseases, including cancer, heart disease, inflammatory diseases, muscle wasting diseases, and neurological disorders. The invention features an isolated modified B cell, known as a CAR-B cell, which is capable of expressing a chimeric receptor. This chimeric receptor includes an extracellular domain, a transmembrane domain, and a cytoplasmic domain that comprises at least one signaling domain. Additionally, the modified B cell can express and secrete a payload, such as an antibody or its fragment, which is not naturally expressed in a B cell or is expressed at higher levels than typically found.

Career Highlights

Kathleen Boyle's career is marked by her dedication to research and innovation in the biotechnology sector. She is currently associated with Walking Fish Therapeutics, where she continues to explore the potential of modified B cells in therapeutic applications. Her work has garnered attention for its potential to revolutionize treatment options for various diseases.

Collaborations

Kathleen collaborates with talented professionals in her field, including Hangil Park and Srinivas Kothakota. These collaborations enhance her research efforts and contribute to the advancement of innovative solutions in genetic engineering.

Conclusion

Kathleen Boyle's contributions to the field of genetic engineering, particularly through her patented work on modified B cells, highlight her role as a leading innovator. Her dedication to addressing critical health challenges through scientific advancements is commendable.